In a 2023 update to the recommended pediatric immunization schedule, the CDC has included recommendations for the COVID-19 vaccine starting at six months. While these guidelines do not force or mandate...
On January 24, 2024, the FDA issued a new draft guidance regarding lead levels in processed baby food meant for children under two as part of its Closer to Zero initiative. The Closer to Zero...
As respiratory syncytial virus (RSV), influenza (flu), and COVID-19 cases surge across the United States, pharmacists are encouraged to use their advanced healthcare role to educate patients and caregivers about preventing the transmission...
On January 9, 2023, the American Academy of Pediatrics (AAP) released its clinical practice guidelines for evaluating and treating pediatric obesity. These updated practices encourage comprehensive...
Over the past few years, healthcare professionals and public health experts have seen the resurgence of many diseases that were once obsolete or nearly obsolete. In part, these rising rates have been...
The clinical trial landscape — globally and in the United States — is one of many complexities, difficulties, implications, and guidelines. Clinical trials can provide critical information on treating chronic and acute...
In recent months, patients, parents, and providers have become increasingly aware of the rise in viral infection rates. With the tripledemic — including COVID-19, respiratory syncytial virus...
According to the CDC, 20% of children and adolescents in the United States deal with pediatric obesity. Obesity is linked with high blood pressure, high cholesterol, type 2 diabetes, joint problems,...
As more and more providers warn against the tripledemic — including RSV, COVID, and influenza — it is crucial to understand the projections and impacts of these cases. Additionally, an in-depth understanding of the tools and...
After producing strong clinical trial results for its respiratory syncytial virus (RSV) vaccine, Pfizer says it is ending enrollment in its study and preparing to submit for FDA approval.
The Phase 3...
Antimicrobial stewardship is a plan to improve antibiotic use and prescription. Many organizations, such as Children's Hospital Colorado, are working to enhance antimicrobial stewardship practices. Michael Bozzella, DO, infectious...
In January 2022, Omnipod 5 was first approved for anyone over six. Omnipod 5 is the first tubeless automated insulin delivery (AID) made available in the United States for a broad age range. Recently,...
As the COVID pandemic progresses and infection rates fluctuate, public health officials and organizations seek to provide more options to protect against illness. On August 19, Novavax announced that...
Unintended pregnancy threatens public health and is exacerbated by limited access and understanding of female contraceptives. The CDC identifies unintended pregnancy as “a pregnancy that is either unwanted, such as the...
The Kaiser Family Foundation (KFF) recently found that pediatric COVID-19 vaccination rates in children under 5 years old have decreased despite the age bracket’s very recent eligibility....
Recently, the FDA approved Qsymia for chronic weight management in pediatric patients over 12 years old. Qsymia is an extended-release pill composed of phentermine and topiramate. The drug’s...
The HPV vaccine rates have increased in adolescents. Between 2015 and 2020, the rate of HPV vaccination in juveniles expanded by 19.3%. This study looked at data from the National Immunization Surveys...
The FDA recently approved the Imcivree (setmelanotide) injection as a weight-management treatment for adults and children over 6 with Bardet–Biedl Syndrome (BBS). BBS is a relatively...
On June 15, the FDA advisory board unilaterally voted to approve Pfizer’s COVID vaccine for children under 5. Until now, there has been a gap in COVID-related care for children under 5 as...
Roche recently announced new three-year data of its study evaluating Evrysdi (risdiplam) in infants with symptomatic Type 1 spinal muscular atrophy (SMA).
The FIREFISH study evaluated the...